Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
Upcoming Clinical Trials
-
NCT07939295Not yet recruitingParkinson's Disease (PD) | Advanced Primary PD
-
NCT07937410RecruitingChronic Subdural Hematoma | Recurrent
-
NCT07940348Not yet recruitingBreast Cancer | Ductal Carcinoma In Situ
-
NCT07938060Not yet recruitingNSTEMI | Unstable Angina (UA) | Angina (Stable)
-
NCT07940426Not yet recruiting
-
NCT07937930Recruiting
-
NCT07905092Not yet recruiting
-
NCT07938528Not yet recruitingDrug-coated Balloon | Intravascular Ultrasound | De Novo Large Coronary Vessel
-
NCT07938281Not yet recruitingAF - Atrial Fibrillation
-
NCT07938177RecruitingClinical High Risk for Psychosis
-
NCT07940283Not yet recruitingMental Health | Psychological Stress
-
NCT07938567Not yet recruitingPregnancy Related | Hypertensive Disorder of Pregnancy (HDP)